Search filters

Filters
Clear All

Phase

  • 54
  • 61
  • 2
  • 53
  • 1
  • 51
  • 11
  • 670
  • 926
  • 606
  • 5
  • 39
  • 886

Found 930 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

99 years and younger
All genders
The purpose of this study is understand changes in cognition, physical abilities, and quality of life of individuals receiving venetoclax-based chemotherapy.
99 years and younger
All genders
Primary Objectives Early phase study to collect and characterize FAP expression imaging in suspected fibrotic tissues related to a variety of suspected fibrosis-inducing conditions, including cancers and non-oncologic conditions, using [F-18]-FAPI-74 PET/CT Secondary Objectives To correlate [F-18]-FAPI-74 uptake measures with clinical outcomes after therapeutic intervention, when applicable. To correlate [F-18]-FAPI-74 …
99 years and younger
All genders
To determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 …
99 years and younger
All genders
This trial evaluates the effects of His or left bundle branch pacing (LBBP) comparative to biventricular pacing on quality of life, exercise capacity, hospitalization for heart failure, and mortality in patients with HF and conduction system disease. Study population is patients with heart failure with reduced ejection fraction (HFrEF) less …
99 years and younger
All genders
This phase II Lung-MAP trial studies how well rucaparib works in treating patients with genomic loss of heterozygosity (LOH) high and/or deleterious BRCA1/2 mutation stage IV non-small cell lung cancer or that has come back. Rucaparib may stop the growth of tumor cells by blocking some of the enzymes needed …
99 years and younger
All genders
Study A35-009 is a two-phase study to evaluate the efficacy and safety of AMX0035 in participants with PSP, consisting of a randomized, double-blind, placebo-controlled phase followed by an optional open-label extension (OLE) phase. The double-blind phase of the study consists of a Screening Period of up to 6 weeks, a …
99 years and younger
All genders
The purpose of this study is to find out whether brigimadlin (BI 907828) is tolerated by and helps people with DDLPS. Brigimadlin is a so-called MDM2 inhibitor that is being developed to treat cancer. We would like to rely on Advarra as the IRB of record for this study.
 Rubella-Associated Granulomatous Lesions
18-99 years
All genders
The project will estimate the prevalence of RV-associated cutaneous granulomas in normal adult population over a 15-year period and assess the frequency and intensity of virus shedding by these long-term RV carriers. These results will help ascertain the impact of long-term RV carriers that could influence the maintenance of rubella …
 NRG-GI008: Colon Adjuvant Chemotherapy Based on Evaluation or Residual Disease (Circulate-North America)
100 years and younger
All genders
Phase 2/3
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absence of circulating tumor DNA (ctDNA) after surgery for colon cancer.This study is Enrolling by Invitation only at Lancaster General Health - ABBCI.
 DCM-DETECT: Dilated Cardiomyopathy Detection using AI and screening with mobile Technology
18-100 years
All genders
At home care (AHC) Artificial Intelligence Electrocardiogram (AI-ECG) can improve cardiac screening by echocardiogram for first degree relatives (FDR) of patients with dilated cardiomyopathy (DCM). Probands will contact their FDRs about testing with an AI-ECG mobile device. This study compares the impact of screening FDR of probands with DCM using …
681 - 690 of 930